Christine Fillmore Brainson

9PUBLICATIONS

36CO-AUTHORS

Medical devicesMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 12, 2026

A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer.

|Aug 12, 2025

Single-cell profiling of EZH2-mediated immune signaling perturbations in NSCLC.

Daniel R Plaugher, Avery R Childress, Christian M Gosser

|Mar 12, 2025

Glycogen drives tumour initiation and progression in lung adenocarcinoma.

Harrison A Clarke, Tara R Hawkinson, Cameron J Shedlock

|Jul 09, 2024

Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response.

Kassandra J Naughton, Xiulong Song, Avery R Childress

|Jan 24, 2024

EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.

Tanner J DuCote, Xiulong Song, Kassandra J Naughton

|Jan 20, 2023

Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors.

Fan Chen, Aria L Byrd, Jinpeng Liu

Pageof 2

Frequent Collaborators

Abigail R Gellert

Daniel R Plaugher

Caroline G Fahey

Francisco J Sanchez-Rivera

Patrizia Pessina

Monica Schenone

Steven A Carr

Yifan Kong

Stuart H Orkin

Yanquan Zhang

Frequent Collaborators

Abigail R Gellert

Daniel R Plaugher

Caroline G Fahey

Francisco J Sanchez-Rivera